Effect of monocrotophos, an organophosphorus insecticide, on the striatal dopaminergic system in a mouse model of Parkinson's disease

被引:10
|
作者
Ali, Shaheen Jafri [1 ]
Rajini, Padmanabhan Sharda [1 ]
机构
[1] Cent Food Technol Res Inst, CSIR, Dept Food Protectants & Infestat Control, Mysore 570020, Karnataka, India
关键词
Dopamine; mice; monocrotophos; oxidative stress; Parkinson's disease; striatum; tyrosine hydroxylase; ACUTE CHLORPYRIFOS EXPOSURE; INDUCED OXIDATIVE STRESS; ALPHA-SYNUCLEIN; TIME-COURSE; VITAMIN-C; PESTICIDES; ACETYLCHOLINESTERASE; MPTP; DAMAGE; BRAIN;
D O I
10.1177/0748233714547733
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Our earlier study had shown that low concentrations of monocrotophos (MCP) elicited dopaminergic features of Parkinson's disease (PD) in the nematode Caenorhabditis elegans. In the present study, the effect of low doses of MCP on the striatal dopaminergic neurons was investigated using the mouse model system. MCP was initially screened for its ability to cause any neurobehavioral deficits and alterations in the dopaminergic system in Swiss albino mice, aged 8 weeks and weighing 25-30 g, with repeated doses at 0.3 and 0.6 mg/kg body weight (b.w.)/day for 7 days and 30 days. Mice were treated with four intraperitoneal injections for every 2 h with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) at the dosage of 14 mg/kg b.w. MCP was administered to these mice at the above-mentioned doses for 7 days. Mice administered with MCP alone revealed a significant < 0.05) reduction in the dopamine (DA) content at both 7 and 30 days and showed a significant (p < 0.05) increase in neurobehavioral deficits. Interestingly, when MCP was administered for 7 days to MPTP-treated mice, further significant decrease in both DA content and increase in neurobehavioral deficits were apparent. The extent of reactive oxygen species and lipid peroxidation were markedly increased, while the ratio of reduced to oxidized glutathione levels were significantly decreased (p < 0.05) in the treated mice as compared to the control. Significant histopathological alterations and a marked reduction in the number of tyrosine hydroxylase positive cells were evident in striatum of mice treated with higher doses of MCP. These changes were comparable to that seen in mice treated with MPTP and post-administered lower doses of MCP. Our findings suggest that MCP per se has the propensity to induce pathological changes in the dopaminergic neurons as well as augment the degeneration in a compromised nigrostriatal system such as that in PD.
引用
收藏
页码:1153 / 1165
页数:13
相关论文
共 50 条
  • [1] Elicitation of Dopaminergic Features of Parkinson's Disease in C. elegans by Monocrotophos, an Organophosphorous Insecticide
    Ali, Shaheen Jafri
    Rajini, Padmanabhan Sharda
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (08) : 993 - 1000
  • [2] Degeneration of nigrostriatal dopaminergic neurons in an experimental model of the early clinical stage of Parkinson's disease
    Kolacheva, A. A.
    Kozina, E. A.
    Volina, E. V.
    Ugryumov, M. V.
    NEUROCHEMICAL JOURNAL, 2014, 8 (03) : 184 - 192
  • [3] Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease
    St-Amour, Isabelle
    Bousquet, Melanie
    Pare, Isabelle
    Drouin-Ouellet, Janelle
    Cicchetti, Francesca
    Bazin, Renee
    Calon, Frederic
    JOURNAL OF NEUROINFLAMMATION, 2012, 9
  • [4] Dopaminergic modulation of striatal function and Parkinson’s disease
    Shenyu Zhai
    Weixing Shen
    Steven M. Graves
    D. James Surmeier
    Journal of Neural Transmission, 2019, 126 : 411 - 422
  • [5] Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson's Disease
    Schintu, Nicoletta
    Frau, Lucia
    Ibba, Marcello
    Garau, Arianna
    Carboni, Ezio
    Carta, Anna R.
    NEUROTOXICITY RESEARCH, 2009, 16 (02) : 127 - 139
  • [6] Dopaminergic modulation of striatal function and Parkinson's disease
    Zhai, Shenyu
    Shen, Weixing
    Graves, Steven M.
    Surmeier, D. James
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (04) : 411 - 422
  • [7] Characterization of the Striatal Extracellular Matrix in a Mouse Model of Parkinson's Disease
    Freitas, Ana
    Aroso, Miguel
    Barros, Antonio
    Fernandez, Miriam
    Conde-Sousa, Eduardo
    Leite, Marina
    Carvalho, Eva Daniela
    Ribeiro, Cristina C.
    Ferreira, Rita
    Pego, Ana Paula
    Vitorino, Rui
    Gomez-Lazaro, Maria
    ANTIOXIDANTS, 2021, 10 (07)
  • [8] Hydrogen Sulfide Functions as a Neuromodulator To Regulate Striatal Neurotransmission in a Mouse Model of Parkinson's Disease
    Wang, Min
    Zhu, Jun
    Pan, Yang
    Dong, Jingde
    Zhang, Lili
    Zhang, Xiangrong
    Zhang, Li
    JOURNAL OF NEUROSCIENCE RESEARCH, 2015, 93 (03) : 487 - 494
  • [9] Degeneration of nigrostriatal dopaminergic neurons in an experimental model of the early clinical stage of Parkinson’s disease
    A. A. Kolacheva
    E. A. Kozina
    E. V. Volina
    M. V. Ugryumov
    Neurochemical Journal, 2014, 8 : 184 - 192
  • [10] Striatal dopaminergic denervation and hypomimia in Parkinson's disease
    Pasquini, J.
    Pavese, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (01) : E2 - E3